ASHTANG GHRITA: A NOBLE AYURVEDA DRUG FOR CENTRAL NERVOUS SYSTEM
DOI:
https://doi.org/10.70066/jahm.v3i2.235Keywords:
Ashtang Ghrita, ,CNS Protective, NeurotropicAbstract
Brain and mind disorders include a wide range of common neurological and psychiatric illnesses. They afflict a very
significant portion of the population, right across the life span. Ayurveda has a deep insight about the treatment of the
problems of the nervous system.The study was done with the aim to review the CNS protective and neurotropic activity of
an Ayurveda drug Ashtang Ghrita. Contents of Ashtang Ghrita have been found to be effective against number of CNS
disorders including Alzheimer’s disease, Parkinsonism, Epilepsy, ADHD, Cerebral palsy etc. by their antioxidant,
neurotropic, nerve regenerating, regularization of neurotransmitter etc. properties and also the drug is in the Ghee form
hence by virtue of its lipid soluble property it can cross Blood brain barrier (BBB) thus proving as an effective drug for CNS.
Toxicological analysis also proves the drug to be absolutely safe for use. The contents of the drug also possess properties of
an effective nervine tonic by means of their endeavor in improving memory and intellect. Thus Ashtang Ghrita can prove
to be a good neurotropic drug both as a prophylactic and curative medication for various CNS disorders and as a nervine
tonic among children.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Sumeet Goel
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.
